BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 proto-oncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes

Blood

Volumn 86, Issue 5, 1995, Pages 1893-1902

  Oudejans, J J ^a   Van Den Brule, A J C ^a   Jiwa, N M ^a   De Bruin, P C ^a   Ossenkoppele, G J ^a   Van Der Valk, P ^a   Walboomers, J M M ^a   Meijer, C J L M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTO ONCOGENE; VIRUS CARCINOGENESIS;

EID: 0029135134     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v86.5.1893.bloodjournal8651893     Document Type: Article

References (49)

1. Miller G: Epstein-Barr virus. Biology, pathogenesis, and medical aspects, in Fields BN, Knipe DM (eds): Fields Virology, 2nd ed. New York, NY, Raven Press, 1990, p 1901
2. Raab-Traub N: Epstein-Barr virus and nasopharyngeal carcinoma. Semin Cancer Biol 3:297, 1992
3. Weiss LM, Movahed LA, Warnke RA, Sklar J: Detection of Epstein-Barr viral genomes in Reed Sternberg cells of Hodgkin's disease. N Engl J Med 320:502, 1989
4. De Bruin PC, Jiwa NM, van der Valk P, van Heerde P, Meijer CJLM: Detection of Epstein-Barr virus nucleic acid sequences and protein in nodal T-cell lymphomas: Relation between latent membrane protein 1 positivity and clinical course. Histopathology 23:509, 1993
5. De Bruin PC, Jiwa M, Oudejans JJ, van der Valk P, van Heerde P, Sabourin J, Csanaky G, Gaulard P, Noorduyn A, Willemze R, Meijer CJLM: Presence of Epstein-Barr virus in extranodal T-cell lymphomas: Differences in relation to site. Blood 83:1612, 1994
6. Korbjuhn P, Anagnostopoulos I, Hummel M, Tremann M, Dallenbach F, Parwaresch MR, Stein H: Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunedeficiency virus negative European peripheral pleiomorphic T-cell lymphomas. Blood 82:217, 1993
7. Lenoir G, Bornkamm GW: Burkitt's lymphoma: A human cancer model for the multistep development of cancer: A proposal for a new scenario. Adv Viral Oncol 6:173, 1986
8. Young L, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, Ritz J, Shapiro RS, Rickinson AB, Kieff E, Cohen JL: Expression of Epstein-Barr virus transformation associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321:1080, 1989
9. Hamilton-Dutoit SJ, Pallesen G, Franzmann MB, Karkov J, Black F, Skinhoj P, Pedersen C: AIDS-related lymphoma. Histopathology, immunophenotype and association with Epstein-Barr virus as demonstrated by in-situ nucleic acid hybridisation. Am J Pathol 138:149, 1991
10. Hamilton-Dutoit SJ, Pallesen G: Detection of Epstein-Barr virus small RNAs in routine paraffin sections using non-isotopic RNA/RNA in situ hybridization. Histopathology 25:101, 1994
11. Niedobitek G, Herbst H, Young LS, Brooks L, Masucci MG, Crocker J, Rickinson AB, Stein H: Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood 79:2520, 1992
12. Gratama JW, Oosterveer MAP, Zwaan FE, Lepoutre J, Klein G, Ernberg I: Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: Implications for sites of viral latency. Proc Natl Acad Sci USA 85:8693, 1988
13. Howe JG, Steitz JA: Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc Natl Acad Sci USA 83:9006, 1986
14. Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB: Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B-lymphocytes. J Virol 66:122, 1992
15. Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB: Differences in B-cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma. EMBO J 6:2743, 1987
16. Brooks LA, Lear AL, Young LS, Rickinson AB: Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency. J Virol 67:3182, 1993
17. Brooks L, Yao QY, Rickinson AB, Young LS: Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: Coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 66:2689, 1992
18. Deacon EM, Pallesen G, Nieboditek G, Crocker J, Brooks L, Rickinson AB, Young LS: Epstein-Barr virus and Hodgkin's disease: Transcriptional analysis of virus latency in the malignant cells. J Exp Med 177:339, 1993
19. Chen C, Sadler RH, Walling DM, Su IH, Hsieh H, Raab-Traub N: Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J Virol 67:6303, 1993
20. Gratama JW, Zutter MM, Minarovits J, Oosterveer MA, Thomas ED, Klein G, Ernberg I: Expression of Epstein-Barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients. Int J Cancer 47:188, 1991
21. Speck SH, Strominger JL: Transcription of Epstein-Barr virus in latently infected, growth-transformed lymphocytes. Adv Viral Oncol 8:133, 1989
22. Tsujimoto Y, Fongen LK, Yunis J, Noweel PC, Croce CM: Cloning of the chromosome breakpoint of the neoplastic B-cells with the t(14-18) chromosome translocation. Science 226:1097, 1984
23. Yin XM, Oltval ZN, Korsmeyer SJ: BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with bax. Nature 369:321, 1994
24. Takayama S, Cazalshatem DL, Kitada S, Tanaka S, Miyashita T, Hovey LR, Huen D, Rickinson A, Veerapandian P, Krajewski S, Saito K, Reed JC: Evolutionary conservation of function among mammalian, avian, and viral homologs of the Bcl-2 oncoprotein. DNA Cell Biol 13:679, 1994
25. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A: Epstein-Barr virus-coded BHRF1 protein, a viral homologue of bcl-2, protects human B-cells from programmed cell death. Proc Natl Acad Sci USA 90:8479, 1993
26. Pearson GR, Luka J, Petti L, Sample J, Birkenbach M, Braun D, Kieff E: Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology 160:151, 1987
27. Marchini A, Tomkinson B, Cohen JI, Kieff E: The Epstein-Barr virus gene with homology to bcl-2, is dispensable for B-lymphocyte transformation and virus replication. J Virol 65:5991, 1991
28. Lee MA, Yates JL: BHRF1 of Epstein-Barr virus, which is homologous to human protooncogene bcl-2, is not essential for transformation of B-cells or for virus replication in vitro. J Virol 66:1899, 1992
29. Austin PJ, Flemington E, Yandawa CN, Strominger JL, Speck SH: Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lyrically infected B lymphocytes. Proc Natl Acad Sci USA 85:3678, 1988
30. Stansfeld AG, Diebold D, Kapanci Y, Kelenyi G, Lennert K, Mioduszewska O, Noel H, Rilke F, Sundstrom C, Van Unnik JAM, Wright D: Updated Kiel classification of non Hodgkin's lymphomas. Lancet 1:292, 1988
31. Jiwa NM, Kanavaros P, van der Valk P, Walboomers JMM, Horstman A, Vos W, Mullink H, Meijer CJLM: Expression of c-myc and bcl-2 oncogene products in Reed Sternberg cells independent of presence for EBV. J Clin Pathol 46:211, 1993
32. Weiss LM, Jaffe ES, Liu X-F, Chen Y-Y, Shibata D, Medeiros LJ: Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood 79:1789, 1992
33. Anagnostopoulos I, Hummel M, Tiemann M, Korbjuhn P, Parwaresch MR, Stein H: Frequent presence of latent-Epstein-Barr virus infection in lymphoepithelioid cell lymphoma (Lennert's lymphoma). Histopathology 25:331, 1994
34. Middleton T, Gahn TA, Martin JM, Sugden B: Immortalizing genes of Epstein-Barr virus. Adv Virus Res 40:19, 1991
35. Maier JAM, Volulalas P, Roeder D, Manag T: Extension of the life-span of human endothelial cells by an interleukin-1 α antisense oligomer. Science 249:1570, 1990
36. Lear AL, Rowe M, Kurilla MG, Lee S, Henderson S, Kieff E, Rickinson AB: The Epstein-Barr Virus (EBV) nuclear antigen-1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. J Virol 66:7461, 1992
37. Addlinger HK, Delius H, Freese UK, Clarke J, Bornkamm GW: A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes. Virology 141:221, 1985
38. Van den Brule AJC, Cromme FV, Snijders PJF, Smit L, Oudejans CBM, Baak JPA, Meijer CJLM, Walboomers JMM: Non-radioactive RNA in situ hybridization detection of human papillomavirus 16-E7 transcripts in squamous cell carcinomas of the uterine cervix using confocal laser scan microscopy. Am J Pathol 139:1037, 1991
39. Hamilton-Dutoit SJ, Rea D, Raphael M, Sandvej K, Delecluse HJ, Gisselbrecht C, Marelle L, van-Krieken HJ, Pallesen G: Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. Am J Pathol 143:1072, 1993
40. Sample J, Brooks L, Sample C, Young L, Rowe M, Gregory C, Rickinson AB, Kieff E: Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc Natl Acad Sci USA 88:6343, 1991
41. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Lisse I, Ralfkiaer E, Sandvej K, Young LS: Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells. J Pathol 165:289, 1991
42. Contreras Brodin BA, Anvret M, Imreh S, Altiok E, Klein G, Masucci MG: B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: Studies with somatic cell hybrids. J Gen Virol 72:3025, 1991
43. Rooney CM, Rowe DT, Ragot T, Farrel PJ: The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. J Virol 63:3109, 1989
44. Weiss LM, Roger MD, Warnke RA, Sklar J, Cleary ML: Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med 317:1185, 1987
45. Ngan BY, Chen-Levy Z, Lawrence D, Weiss M, Warnke RA, Cleary ML: Expression in non Hodgkin lymphoma of the bcl-2 protein associated with the t(14-18) chromosomal translocation. N Engl J Med 318:1638, 1988
46. Offir K, Lo Coco F, Louie D, Parsa NZ, Leung D, Portlock C, Ye BH, Lista F, Filippa DA, Rosenbaum A, Ladanyi M, Jhanwar S, Dalla-Favera R, Chaganti RSK: Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med 331:74, 1994
47. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334, 1990
48. Tarodi B, Subramanian T, Chinnadurai G: Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection. Virology 201:404, 1994
49. Jiwa NM, Oudejans JJ, Dukers DF, Vos W, Horstman A, van der Valk P, Middeldorp JM, Kluin Ph H, Walboomers JMM, Meijer CJLM: Immunohistochemical demonstration of different latent membrane protein-1 epitopes of Epstein-Barr virus in lymphoproliferative diseases. J Clin Pathol 48:438, 1995